RP Cure Tracker

Trials / NCT00231010

Molecular Genetics of Retinal Degenerations

Completed Observational Natural history / observational

Sponsor
National Eye Institute (NEI)
Treatment
Not listed
Gene
Not stated
Conditions
Retinal Degeneration, Retinitis Pigmentosa
Ages
4 Years to no upper limit
Enrollment
3549 participants
Started
2005-09-26
Main results expected
Not stated
Results posted
Not yet
Record last updated
2018-04-05

What the study is testing

This multinational study will investigate the inheritance of genetic retinal degeneration in families of different nationalities and ethnic backgrounds in order to identify the genes that, when altered, cause retinal degeneration. The retina is a light-sensitive membrane lining the back part of the eye. It relays vision signals to the brain, which the brain interprets into sight. When the retina degenerates, vision is altered and possibly lost. The findings of this study should help improve diagnosis and methods of treatment for these disorders. Participating institutions include: the National Institutes for Health in Bethesda, Maryland; the University of Miami in Florida; the Casey Eye Institute in Portland, Oregon; the Byrd Health Sciences Center in Morgantown, West Virginia; the University of Texas Southwestern Medical School in Dallas, Texas; the University of Tennessee Health Sciences Center in Memphis; the Prasad Eye Institute in Hyderabad, India; National Center of Excellence in Molecular Biology in Lahore, Pakistan; and the Jules Gonin Hospital in Lausanne, Switzerland.

Patients with retinitis pigmentosa and closely related diseases such as Usher syndrome, snowflake vitreoretinal dystrophy and Bietti crystalline dystrophy may be eligible for this study. Participants undergo the following tests and procedures:

Where it runs

China (1)
India (1)
Pakistan (1)
United States (3)

Open on ClinicalTrials.gov for contacts and eligibility